Caribou Biosciences, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CRBU on Nasdaq
Location
2929 7 Th Street, Suite 105, Berkeley, California

There are no Buy or Sell transactions made by insiders since 9/12/2023

Caribou Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other* $9.84M Jul 27, 2021
Rachel E. Haurwitz President and CEO, Director $9.7M Feb 20, 2024
Barbara G. Mcclung Chief Legal Officer $1.45M Feb 20, 2024
Steven Kanner Chief Scientific Officer $1.1M Feb 20, 2024
Timothy P. Kelly Chief Technology Officer $807K Jan 8, 2024
Jason O'Byrne Chief Financial Officer $512K Feb 20, 2024
Ruhi Ahmad Khan Chief Business Officer $441K Feb 20, 2024
Ryan Fischesser VP of Finance and Controller $385K Oct 6, 2022
Syed Ali-aamir Rizvi Chief Medical Officer $352K Feb 21, 2023
David Lee Johnson Director $106K Feb 20, 2024
Dara Richardson-Heron Director $106K Feb 20, 2024
Natalie Sacks Director $106K Feb 20, 2024
Scott Braunstein Director $106K Feb 20, 2024
Andrew Guggenhime Director $106K Feb 20, 2024
Ran Zheng Director $57.8K Feb 20, 2024
Nancy Whiting Director $57.8K Feb 20, 2024
Tina M. Albertson Chief Medical Officer Aug 19, 2024
Jeffrey Long-McGie Director Jul 22, 2021

Recent Insider Transactions by Companies or Individuals for Caribou Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.